Semaglutides effects on the body could potentially contribute to back pain, but its essential to understand the underlying mechanisms
Patients should eat smaller, more frequent meals rather than large portions, as excessive food volume exacerbates delayed gastric emptying
These concerns first gained prominence around 20112013, when regulatory agencies began investigating potential pancreatic safety signals associated with incretin-based therapies, including both GLP-1 receptor agonists and DPP-4 inhibitors
The unmet clinical need is significant, and dual GLP-1/amylin therapy has the potential to address several of these gaps
It is the most extensively studied GLP-1 analogue, providing the reference dataset against which dual and triple agonists are compared
By slowing down the "engine" of pigment production, the body creates less melanin over time